Xeris Pharmaceuticals

Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D

Role: lead

Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism

Role: lead

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Role: lead

Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia

Role: collaborator

Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses

Role: lead

Three Way Crossover Closed Loop Study With Xeris Glucagon

Role: collaborator

G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

Role: lead

Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery

Role: lead

The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

Role: collaborator

Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia

Role: collaborator

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Role: lead

CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism

Role: lead

Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients

Role: lead

Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

Role: lead

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Role: lead

PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients

Role: lead

Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes

Role: lead

G-Pen™ for Hypoglycemia Rescue in T1D Patients

Role: lead

Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia

Role: lead